Order Article Reprints

Earl J, Barreto E, Castillo ME, Fuentes R, Rodríguez-Garrote M, Ferreiro R, Reguera P, Muñoz G, Garcia-Seisdedos D, López JV, et al. Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival. Cancers. 2021; 13(7):1612. https://doi.org/10.3390/cancers13071612

Earl, Julie, Emma Barreto, María E. Castillo, Raquel Fuentes, Mercedes Rodríguez-Garrote, Reyes Ferreiro, Pablo Reguera, Gloria Muñoz, David Garcia-Seisdedos, Jorge Villalón López, and et al. 2021. "Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival" Cancers 13, no. 7: 1612. https://doi.org/10.3390/cancers13071612

Earl, J., Barreto, E., Castillo, M. E., Fuentes, R., Rodríguez-Garrote, M., Ferreiro, R., Reguera, P., Muñoz, G., Garcia-Seisdedos, D., López, J. V., Sainz, B., Jr., Malats, N., & Carrato, A. (2021). Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival. Cancers, 13(7), 1612. https://doi.org/10.3390/cancers13071612